Tokyo, Japan, and Cambridge, UK, 6 July 2021 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in GPCR-focused structure-based drug design and development, and InveniAI® LLC (“InveniAI,” Guilford, CT, USA), a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across drug discovery and development, announced today
News
We have taken home the most coveted prize at the inaugural eprivateclient Excellence Awards.
An online black tie gala ceremony was held on 24 June to announce the awards, designed to recognise the outstanding achievements of eprivateclient’s top-ranked firms. This included firms from across the UK working in offshore legal, tax, fiduciary and advisory professional services over the last 12 months. Overall, 66 firms entered the 11 categories, with 27 contestants shortlisted.
We have officially launched LitiGate's AI-driven litigation platform across our network of contentious teams.
The firm has moved from a test phase of the tool on a select number of cases, to a rollout across the wider community of contentious practices involving its application to many of the most significant pieces of litigation or arbitration.
We chose LitiGate as our go-to litigation lifecycle platform to support clients with contentious matters, following our work with the platform's developers during the testing phase.
Brussels South Charleroi BioPark (BSCB) recently announced it has launched a Cell and Gene Therapy Accelerator program to de-risk early stage research and create the advanced therapy companies of the future. Open to academic, industry or independent researchers across Europe, the program consists of an intensive bootcamp, workshops and coaching, plus access to Université libre de Bruxelles (ULB) Open BioLab and state-of-the-art technology platforms.
Click here to view the June edition of Dates for Your Diary
Cambridge, UK: 30 June 2021
One Nucleus, the non-for-profit Life Science membership group headquartered in Cambridge exists to support growing Life Science businesses on their journey, including facilitating their business networking. BiotechBikers is a fast growing, informal global networking group in the Life Sciences space bringing together those with a social interest in cycling and biotech.
AMSBIO have supplied custom lentivectors to Francesco Pampaloni and his team at the Buchmann Institute for Molecular Life Sciences (BMLS) in Frankfurt, Germany allowing them to visualize cell nuclei and F-actin cytoskeleton in their organoids.
Oxford, UK, 29 June 2021: PharmaVentures is pleased to announce that it acted as an independent technical and commercial expert with respect to Spectral MD’s listing on London’s AIM on June 22nd.
SOMERSET, N.J., June 28, 2021 – Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has been recognized by the Royal Society for the Prevention of Accidents (RoSPA) for demonstrating high health and safety standards.